Fatty Liver Index (FLI)
The fatty liver index is calculated from waist circumference, body mass index, triglycerides and GGT to estimate the probability of liver fat without imaging; below 30 makes steatosis unlikely and 60 or above makes it likely.
Plain English
Patient-Friendly Explanation
Fat accumulation in the liver is one of the commonest consequences of excess weight, and it is usually silent. Ultrasound detects it, but ultrasound is not always available, needs a trained operator and adds cost. The fatty liver index was designed as a simple alternative. It combines four measurements already collected in a weight clinic or general practice: waist circumference, body mass index, fasting triglycerides and gamma-glutamyl transferase, a liver enzyme. Those four numbers go into a formula that returns a value between zero and one hundred, which represents the probability that fat is present in the liver. In the original study of nearly five hundred people, a score below thirty made the presence of fat unlikely, with a sensitivity of about eighty-seven per cent, while a score of sixty or above made it likely, with a specificity of about eighty-six per cent and an overall accuracy of about eighty-four per cent compared with ultrasound. Later studies in other populations have confirmed the general shape of this performance while showing that the cut-offs are not identical everywhere. In a large Korean validation, a value of about twenty-nine was the most discriminating, with an area under the curve of 0.82, and the widely quoted cut-off of sixty performed less well. A 2024 study that compared several non-invasive scores found the fatty liver index the strongest single score for fatty liver disease, with areas under the curve of about 0.79 to 0.82, and reported that the threshold differs by sex: about thirty-two in women and sixty in men. The index is not a diagnosis and does not measure scarring. It is a sorting tool: a low score lets you reassure and move on, an intermediate score supports lifestyle treatment and follow-up, and a high score justifies imaging or a liver fibrosis score such as FIB-4 to identify people who need referral. Because triglycerides and the liver enzyme are needed, the test is ideally done fasting, and results should be interpreted alongside alcohol intake, medication and other liver conditions.
Medical
Clinical Definition
The Fatty Liver Index (FLI) is a non-invasive algorithm developed by Bedogni and colleagues (BMC Gastroenterology 2006;6:33) to predict hepatic steatosis: FLI = (e^L / (1 + e^L)) x 100, where L = 0.953 x ln(triglycerides in mg/dL) + 0.139 x body mass index (kg/m2) + 0.718 x ln(GGT in U/L) + 0.053 x waist circumference (cm) - 15.745. In the derivation cohort of 496 participants the area under the receiver operating characteristic curve was 0.84 (95% CI 0.81 to 0.87) with 0.83 (0.79 to 0.86) in the validation cohort and an overall accuracy of 84%. A value below 30 rules out steatosis with a sensitivity of about 87% (negative likelihood ratio 0.2), and a value of 60 or above rules it in with a specificity of about 86% (positive likelihood ratio 4.3); values between 30 and 59 are intermediate. Validation studies in Finnish, German, Dutch, Korean, Chinese and Middle Eastern populations report areas under the curve of about 0.80 to 0.85, but the optimal cut-off varies widely: about 29 (sensitivity 73.4%, specificity 76.1%, AUC 0.82) in an asymptomatic Korean cohort, 40.6 in another analysis and 30.4 in western China. In a 2024 cohort of 1,069 out-patients, the FLI showed the strongest discrimination of the non-invasive tests examined for both steatosis (AUC 0.79, cut-off 55) and metabolic dysfunction-associated steatotic liver disease (AUC 0.82, cut-off 44), with markedly lower optimal thresholds in women (32; sensitivity 0.73, specificity 0.73) than in men (60; sensitivity 0.74, specificity 0.75). The FLI requires fasting triglycerides and GGT, is affected by alcohol use, medication and other causes of a raised GGT, and estimates steatosis rather than fibrosis; the FIB-4 index addresses fibrosis, so the two are complementary, and algorithms that apply the FLI and then FIB-4 are recommended in primary care pathways for people with obesity and cardiometabolic risk factors.
Key Insight
Why It Matters
This is one of the most useful tools for a weight clinic because it turns four routine numbers into a conversation about the liver, and mild liver fat is reversible with a weight loss of about five to ten per cent. The nuance worth keeping in mind is that the cut-off is not universal: values between 30 and 60 mean the answer is genuinely uncertain, and the appropriate response is imaging or a fibrosis score rather than reassurance. It also helps to explain to patients that the score measures fat and not damage, and that a separate calculation is used when the question is scarring.
Where this fits
Fatty Liver Index (FLI) is one of the concepts that comes up in metabolic health and weight at our clinic. If you are reading about it because of your own weight, the next practical step is a clinical assessment — see our medical weight loss programme for how the programme works, what it involves and what it costs.
Sources
Reviewed against standard medical references.
Medically reviewed by
Family Physician & Registered Acupuncturist, Accord Medical Clinic. MBBS (NUS), Graduate Diploma in Family Medicine (NUS), Graduate Diploma in Acupuncture (Singapore College of TCM).
Last reviewed: October 2026
This page is general health education, not medical advice. Whether any treatment is appropriate for you is a decision made in consultation after assessment.